Literature DB >> 3261541

Idiopathic thrombocytopenic purpura in the older adult patient.

T H Guthrie1, D P Brannan, L M Prisant.   

Abstract

Forty adults with idiopathic thrombocytopenic purpura (ITP), aged over 45 years, were seen from March 1954 to December 1983 at the Medical College of Georgia. All patients had bleeding manifestations at presentation. Twenty-one of 40 (52.5%) during the follow-up period had either life-threatening or fatal bleeding episodes. There were no significant differences for the presence of any presenting clinical or laboratory feature for patients who achieved a complete remission compared with those who did not. A complete response to therapy, younger age, higher presenting hemoglobin level, and absence of central nervous system bleeding favorably influenced overall survival. Therapy was ineffective in this age group, with only 12 patients (30%) achieving a permanent complete remission. Fourteen patients (35%) died either from bleeding or from direct complications of therapy. This analysis of ITP in the older adult suggests a disease refractory to therapy that is associated with major morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261541     DOI: 10.1097/00000441-198807000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.

Authors:  Kiarash Kojouri; James N George
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

Review 2.  [Adult autoimmune thrombocytopenia: diagnosis and treatment].

Authors:  Klaus Lechner; Ansgar Weltermann; Ingrid Pabinger
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

3.  Racial variation in ITP prevalence and chronic disease phenotype suggests biological differences.

Authors:  Taylor Olmsted Kim; Amanda B Grimes; Susan E Kirk; Megan M Gilbert; Helen D Reed; Kristen A Staggers; Lauryn A Walker; Abinaya Arulselvan; A Sarah Cohen; Michele P Lambert; Jenny M Despotovic
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

4.  Long-term management of chronic immune thrombocytopenic purpura in adults.

Authors:  Javier Palau; Isidro Jarque; Miguel A Sanz
Journal:  Int J Gen Med       Date:  2010-10-05

5.  Identification and characterization of anti-platelet antibodies in idiopathic thrombocytopenic purpura patients.

Authors:  N Aghabeigi; N Lindsey; A Zamani; B Shishaeyan
Journal:  Iran J Public Health       Date:  2012-02-29       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.